Skip to content

The transition from cannabis induced psychosis to primary psychosis: factors that question the validity of the diagnosis “cannabis-induced psychosis”

E. Rognli

European Psychiatry April 1, 2025 DOI: 10.1192/j.eurpsy.2025.48

Summary

AI-generated from the abstract

A register-based study using Norwegian national patient data from 2010 to 2015 found that people initially diagnosed with substance-induced psychosis face a six-year cumulative risk of later developing schizophrenia of 27.6%. The risk was highest for those whose initial diagnosis was cannabis-induced psychosis, at 36%. These high transition rates raise questions about whether the initial diagnosis was correct or whether the psychosis was an early sign of a primary psychotic disorder masked by cannabis use. The authors argue that the diagnostic label 'cannabis-induced psychosis' overemphasizes substance use and overlooks other factors such as genetic vulnerability.

Study at a glance

Characteristics Register-based study Peer reviewed
Population People in Norway diagnosed with substance-induced psychosis or cannabis-induced psychosis between 2010 and 2015
Duration 6-year follow-up
Key finding The six-year cumulative hazard for transition from cannabis-induced psychosis to schizophrenia was 36%, higher than the 27.6% for any substance-induced psychosis.

Abstract

Abstract Background: Substance-induced psychosis is an acute psychotic condition occurring after substance use, where the psychotic symptoms are alleviated with abstinence. Some of those diagnosed with substance-induced psychosis later develop schizophrenia, and this transition occurs most often for psychosis induced by cannabis. This talk will present results from a register-based study investigating transition rates. The results will be discussed together with other factors that together question the validity of the diagnostic entity of “cannabis-induced psychosis” Method: In our study, we used data from National Patient Register in Norway from 2010 to 2015 to estimate the cumulative hazard for transition from any substance-induced psychosis (F1x.5) and cannabis-induced psychosis (F12.5) to schizophrenia spectrum disorder (F20, F22 and F23). Results: The six-year cumulative hazard for transition from substance-induced psychosis to schizophrenia was 27.6% (25.6-29.7) for any SIP, and highest for those with cannabis-induced psychosis, 36% (95% CI 31.4-41.0). Conclusion: Cannabis-induced psychosis constitutes a significant risk for later schizophrenia. This raises a question of whether the initial diagnosis of CIP was correct, or whether these may have been cases of a development of primary psychosis concealed by cannabis use. Further, the term “cannabis-induced psychosis” places a major explanatory emphasis on the substance use, ignoring other potential contributing factors such as vulnerability including genetic disposition for psychosis.Disclosure of InterestNone Declared

Comments

No comments yet.

Log in to comment